EPL LIMITED — Investor Presentation 2021

May 20, 2021

==> picture [569 x 91] intentionally omitted <==

20 May 2021

20 May 2021
Corporate Service Department	The Listing Department
BSE Limited	National Stock Exchange of India Ltd
25thFloor, Phiroze Jeejeebhoy Towers,	Exchange Plaza, Plot no. C/1, G Block,
Dalal Street, Mumbai 400 001	Bandra-Kurla Complex, Bandra (E)
	Mumbai 400 051
Scrip:Equity 500135.	Trading Symbol:EPL
NCDs 960308, 960310 & 960311.

Ref.: EPL Limited (EPL)

Sub.: Investors notes/updates with respect to the Audited Financial Results for the Quarter and year ended 31 March 2021.

Dear Sirs,

Please find attached copy of the Investors notes/updates as mentioned in the subject line.

We request you to kindly take note of the aforesaid and acknowledge receipt.

Thanking You

Yours faithfully For EPL Limited

==> picture [42 x 46] intentionally omitted <==

Suresh Savaliya Head - Legal & Company Secretary

Encl.: As above

Filed online

==> picture [562 x 82] intentionally omitted <==

EPL LIMITED (Formerly known as Essel Propack Limited) Q4 FY21 Earnings Presentation

EPL Limited Q4FY21 Earnings Presentation

Safe Harbour

Certain statements in this presentation concerning our future growth prospects are forward-looking statements. The Company cautions that, by their nature, forward-looking statements involve risks and uncertainties that could cause actual results to differ materially from those in such forward-looking statements. The risks and uncertainties relating to these statements include, but are not limited to, risks and uncertainties regarding fluctuations in earnings, our ability to manage growth, intense competition in packaging industry including those factors which may affect our cost advantage, wage increases, our ability to attract and retain highly skilled professionals, time and cost overruns on fixed-price, fixed-time frame contracts, client concentration, industry segment concentration, our ability to manage our operations, reduced demand for packaging products in our key focus areas, our ability to successfully complete and integrate potential acquisitions, liability for damages on our service contracts, the success of the companies in which is EPL (Formerly known as Essel Propack Limited) has made strategic investments, withdrawal of governmental fiscal incentives, political instability and regional conflicts, legal restrictions on raising capital or acquiring companies, and unauthorized use of our intellectual property and general economic conditions affecting our industry. The Company does not undertake to update any forward-looking statements that may be made from time to time by or on behalf of the Company.

2

EPL 2.0

Market Leading Revenue Growth and Capital Efficient, Consistent Earnings Growth

3

EPL Limited Q4FY21 Earnings Presentation

FY21 – Transformed EPL to deliver market leading, double digit revenue growth

==> picture [25 x 23] intentionally omitted <==

----- Start of picture text -----

1
----- End of picture text -----

Demonstrated resilience in business performance despite impact of Covid-19

• Double digit revenue growth

• High teens EPS growth

• RoCE improved by 290 bps to 21.3%.

==> picture [25 x 24] intentionally omitted <==

----- Start of picture text -----

2
----- End of picture text -----

Strengthened our competitive position across markets.

• Acquired Creative Stylopack in India

==> picture [25 x 23] intentionally omitted <==

----- Start of picture text -----

3
----- End of picture text -----

Delivered strong progress across all our identified levers:

• Accelerated growth in Personal Care

• Continued leadership in Oral Care

• Improved Performance in Europe

• Industry leadership in eco-friendly solutions

4

EPL Limited Q4FY21 Earnings Presentation

Worked Proactively with All Stakeholders to Ensure Business Continuity and Minimize Covid-19 Impact

Supply Enablement	All plants operational		Proactively worked with regulatory authorities and customers to classify EPL in the “essential services” category
			All plants are currently operational
	New category		Product innovation extended to launch hand washes in tubes.
Demand Generation	launched: Hand Sanitizer/Hand		Envisioning to become a large player in hand wash category going forward.
	wash		Opportunity to increase wallet share in existing categories
Employee	Crisis Committee		Rigorous employeesafety measures adopted across all factories
Wellness	Constituted		Crisis committee constituted comprising CEO, COO, CFO, and regional heads
Cost Management	Project Phoenix		Project Phoenix continues to contribute towards margin enhancement.
			Initiatives and targets identified for FY22.

5

EPL Limited Q4FY21 Earnings Presentation

FY21 - Double digit revenue growth coupled with strong earnings growth

(INR million)

==> picture [638 x 322] intentionally omitted <==

----- Start of picture text -----

FY20 FY21 Growth
Revenue 30,916 12.0%
27,614
Growth [1]
Adjusted EBITDA 6,472 13.4%
5,709
Adjusted EPS (INR) 8.89 34.6%
6.60
As of March’20 As of March’21
ROCE [2] 290 bps
21.3%
18.4%
Capital Includes INR 1675 mm of cash proceeds
Efficiency Net Debt 2,760 3,149 paid for Creative acquisition. Adjusted for
this net debt is INR 1474 mm
FY20 FY21
Capex 1,760
1,286
----- End of picture text -----

(1) Refer page 31 for details on Adjusted EBITDA and Adjusted EPS

(2) Return on Capital Employed, defined as EBIT / Average Capital Employed, on a trailing twelve month basis and adjusted for INR 160 mn in Mar 21 (INR 98 mn for Mar20) of Transition Services Agreement (TSA) related expense , Nil in Mar 21 (INR 11 mn in Mar 20) of tax amnesty expenses and INR 144 mn for Mar 21(Nil for Mar 20) of ESOP related expenses.

6

EPL Limited Q4FY21 Earnings Presentation

FY21 Consolidated Financial Highlights : Double digit revenue growth coupled with strong earnings growth

(INR million)

Revenue from Operations

==> picture [203 x 97] intentionally omitted <==

----- Start of picture text -----

30,916
27,614 12.0 %
FY20 FY21
----- End of picture text -----

EBITDA and EBITDA Margins

==> picture [194 x 98] intentionally omitted <==

----- Start of picture text -----

20.3% 19.9%
5,600 6,155
9.9%
13.4%
FY20 FY21
----- End of picture text -----

EBIT and EBIT Margins

==> picture [196 x 98] intentionally omitted <==

----- Start of picture text -----

12.0% 12.3%
3,809
3,302
15.4%
FY20 FY21
----- End of picture text -----

PAT[1] and EPS (INR)

Net Debt and Net Debt/EBITDA

==> picture [424 x 132] intentionally omitted <==

----- Start of picture text -----

6.87 8.09 0.49x 0.51x
2,552
2,167 2,760 3,149
17.8%
34.6%
FY20 FY21 FY20 FY21
Adjusted growth % Includes INR 1675 mm of cash proceeds paid for Creative
acquisition. Adjusted for this net debt is INR 1474 mm
----- End of picture text -----

ROCE[2]

==> picture [195 x 103] intentionally omitted <==

----- Start of picture text -----

21.3%
18.4%
290 bps
FY20 FY21
----- End of picture text -----

• Robust revenue and PAT growth despite Covid-19. Organic revenue growth at 11.3%

• EBIDTA margin maintained despite steep RM price increase and Covid-19 situation.

• Net Debt to EBIDTA at strong 0.5 times.

• Focus on capital efficiency yielding results, driving increase in ROCE to 21.3%.

• (1) Excluding exceptional items (2) Return on Capital Employed, defined as EBIT / Average Capital Employed, on a trailing twelve-month basis and adjusted for INR 160 mn in Mar 21 (INR 98 mn for Mar20) of Transition Services Agreement (TSA) related expense , Nil in Mar 21 (INR 11 mn in Mar 20) of tax amnesty expenses and INR 144 mn for Mar 21(Nil for Mar 20) of ESOP related expenses.

7

EPL Limited Q4FY21 Earnings Presentation

EPL - Double digit revenue growth coupled with strong earnings growth

(INR million)

==> picture [544 x 322] intentionally omitted <==

----- Start of picture text -----

Q4FY20 Q4FY21 Growth
Revenue 8,102 17.5%
6,896
Growth [1]
Adjusted EBITDA 1,450 1,527 5.3%
Adjusted EPS (INR) 1.64 2.12 29.6%
As of March’20 As of March’21
ROCE [2] 21.3% 290 bps
18.4%
Capital
Efficiency Net Debt 2,760 3,149
FY20 FY21
Capex
1,760
1,286
----- End of picture text -----

Includes INR 1675 mm of cash proceeds paid for Creative acquisition. Adjusted for this net debt is INR 1474 mm

(1) Refer page 32 for details on Adjusted EBITDA and Adjusted EPS

(2) Return on Capital Employed, defined as EBIT / Average Capital Employed, on a trailing twelve month basis and adjusted for INR 160 mn in Mar 21 (INR 98 mn for Mar20) of Transition Services Agreement (TSA) related expense , Nil in Mar 21 (INR 11 mn in Mar 20) of tax amnesty expenses and INR 144 mn for Mar 21(Nil for Mar 20) of ESOP related expenses.

8

EPL Limited Q4FY21 Earnings Presentation

Q4FY21 Consolidated Financial Highlights : Strong revenue growth of 17.5% with high teen growth in PAT

(INR million)

Revenue from Operations

==> picture [195 x 107] intentionally omitted <==

----- Start of picture text -----

8,102
6,896
17.5 %
Q4FY20 Q4FY21
----- End of picture text -----

EBITDA and EBITDA Margins

==> picture [188 x 109] intentionally omitted <==

----- Start of picture text -----

20.4% 17.5%
1,410 0.4% 1,416
5.3%
Q4FY20 Q4FY21
----- End of picture text -----

EBIT and EBIT Margins

==> picture [198 x 109] intentionally omitted <==

----- Start of picture text -----

12.1% 10.1%
836 815
-2.5%
Q4FY20 Q4FY21
----- End of picture text -----

PAT[1] and EPS (INR)

Net Debt and Net Debt/ LTM EBITDA

==> picture [416 x 125] intentionally omitted <==

----- Start of picture text -----

1.54 1.80 0.49x 0.51x
568 2,760 3,149
486
16.9%
29.7%
Q4FY20 Q4FY21 FY20 FY21
Adjusted growth % Includes INR 1675 mm of cash proceeds paid for Creative
acquisition. Adjusted for this net debt is INR 1474 mm
----- End of picture text -----

ROCE[2]

==> picture [195 x 109] intentionally omitted <==

----- Start of picture text -----

21.3%
18.4%
290 bps
FY20 FY21
----- End of picture text -----

• Robust revenue and PAT growth despite Covid-19. Organic Revenue growth at 14.9%

• EBITDA growth lower than revenue growth because of steep increase in raw material prices, time lag in recoveries and Covid-19 related one-time operational expenses.

• (1) Excluding exceptional items (2) Return on Capital Employed, defined as EBIT / Average Capital Employed, on a trailing twelve month basis and adjusted for INR 160 mn in Mar 21 (INR 98 mn for Mar20) of Transition Services Agreement (TSA) related expense , Nil in Mar 21 (INR 11 mn in Mar 20) of tax amnesty expenses and INR 144 mn for Mar 21(Nil for Mar 20) of ESOP related expenses.

9

EPL Limited Q4FY21 Earnings Presentation

Unprecedented price increase in key raw materials

==> picture [375 x 158] intentionally omitted <==

----- Start of picture text -----

Polymer Movement
2600
1850
2400
1650
2200
1450 2000
1250 1800
1050 1600
850 1400
650 1200
USD/ MT USD/ MT
----- End of picture text -----

==> picture [99 x 11] intentionally omitted <==

----- Start of picture text -----

Foil Movement
----- End of picture text -----

==> picture [42 x 90] intentionally omitted <==

==> picture [508 x 44] intentionally omitted <==

----- Start of picture text -----

Month Month
LLDPE HDPE LME SHFE
Source – ICIS M LLDPE and HDPE Index Source – LME and SHFE Index
----- End of picture text -----

• Unprecedented RM price increase of ~ 25% QoQ as against historical movement in the broad band of +/-5%

10

EPL Limited Q4FY21 Earnings Presentation

Holistic EBITDA margin improvement plan in place

Holistic EBITDA margin improvement plan already in place for FY22 through a three-pronged approach:

1 Judicious Price Increases

• Contractual pass-through in long term contracts has a 3-month lag

• Price corrections being negotiated across geographies to offset the raw material price increase

2 Cost Productivity Initiatives: Project Phoenix Phase II

• “Modern Times”: Improving manufacturing efficiency through automation

• Increased in-house manufacturing of caps and closures

• Scrap and wastage reduction

• Rationalization of energy consumption

• 3 Mix Improvement  Focus on higher-profit segments and value-added offerings

11

EPL Limited Q4FY21 Earnings Presentation

Continued Focus on Capital Efficiency

==> picture [625 x 331] intentionally omitted <==

----- Start of picture text -----

3,040
Prudent Capex Spend.. 2,305 1,405 1,286 1,760
FY17 FY18 FY19 FY20 FY21
Capital Expenditure (INR million)
7,035
..Leading to Reduction 5,636 4,998
in Net Debt 2,760 3,149
FY17 FY18 FY19 FY20 FY21
Net Debt (INR million)
…Continuous
improvement in ROCE [1] 16.9% 17.2% 17.0% 18.4% 21.3%
driven by prudent
capital allocation
FY17 FY18 FY19 FY20 FY21
ROCE [1]
Final Dividend Interim Dividend 2.05
2.05
..And Higher Dividends 1.20 1.20 1.25 1.25 2.05
for Shareholders [2]
FY17 FY18 FY19 FY20 FY21
Annual + Interim Dividend
----- End of picture text -----

• (1) Return on Capital Employed, defined as EBIT / Average Capital Employed, on a trailing twelve-month basis and adjusted for INR 160 mn in Mar 21 (INR 98 mn for Mar20) of Transition Services Agreement (TSA) related expense , Nil in Mar 21 (INR 11 mn in Mar 20) of tax amnesty expenses and INR 144 mn for Mar 21(Nil for Mar 20) of ESOP related expenses.

• (2) Dividend adjusted for bonus shares to make it comparable

12

EPL Limited Q4FY21 Earnings Presentation

Delivered strong progress across all our identified levers

• Accelerated growth in Personal Care

• Continued leadership in Oral Care

• Improved Performance in Europe

• Industry leadership in eco-friendly solutions

13

EPL Limited Q4FY21 Earnings Presentation

Personal Care has grown at a 15.7% CAGR Over the Last Ten Years and Continues to be the Major Growth Driver for EPL in FY21

Personal Care Revenue (INR million)

==> picture [636 x 328] intentionally omitted <==

----- Start of picture text -----

Growth 14.7 %
Y-o-Y
2,980 8,254 11,206 12,852
Sub-categories FY11 FY15 FY20 FY21
Face Care
Hair Care
OTC Medication
Prescription Medication
Food
Home
Hygiene Products
Eye Care Actively
Pursuing
Hand Cream
Actively
New Applicator (B&C) Pursuing
Ongoing shift towards laminated tubes across Beauty & Cosmetics and Pharma is driving growth in Personal Care
----- End of picture text -----

14

EPL Limited Q4FY21 Earnings Presentation

Personal Care Contribution stood at 46% in FY21

Personal Care Contribution to Tube Revenue

==> picture [596 x 237] intentionally omitted <==

----- Start of picture text -----

46%
45%
43%
41%
FY18 FY19 FY20 FY21
----- End of picture text -----

Despite clear headwinds in B&C, Personal care share held by increased demand of Hygiene Products

15

EPL Limited Q4FY21 Earnings Presentation

Continued Growth in Personal Care (1/2)

(INR million)

AMESA

==> picture [260 x 196] intentionally omitted <==

----- Start of picture text -----

0.0% CAGR
Growth 2.1%
Y-o-Y
3,917 3,821 3,839 3,920
FY18 FY19 FY20 FY21
----- End of picture text -----

Highlights

• Personal Care contribution declined to 49.2% in FY21 (v/s 49.9% in FY20), due to sluggish demand in B&C on account of ongoing Covid-19 outbreak, However B&C has recovered in the second half.

==> picture [18 x 8] intentionally omitted <==

----- Start of picture text -----

EAP
----- End of picture text -----

==> picture [263 x 183] intentionally omitted <==

----- Start of picture text -----

Growth 52.0%
Y-o-Y
1,158 1,611 1,698 2,581
FY18 FY19 FY20 FY21
----- End of picture text -----

Highlights

• Personal Care contribution increased to 40.4% in FY21 (v/s 34.5% in FY20). Growth is majorly driven by B&C and Pharma segments.

• Strong business pipeline and increased focus on fast-growing regional players has driven robust growth in FY21.

• Timely innovation and launch of Hygiene products aided in boosting the FY21 performance.

16

EPL Limited Q4FY21 Earnings Presentation

Continued Growth in Personal Care (2/2)

(INR million)

Americas

==> picture [255 x 186] intentionally omitted <==

----- Start of picture text -----

Growth 5.8%
Y-o-Y
896 1,277 1,496 1,582
FY18 FY19 FY20 FY21
----- End of picture text -----

Highlights

• Personal Care contribution is maintained at 25.0% in FY21 (v/s 25.4% FY20).

• New customer wins across categories; bottle to tube product conversions; cross-selling Personal Care products to existing Oral care customers

==> picture [262 x 224] intentionally omitted <==

----- Start of picture text -----

Europe
Growth 14.7%
Y-o-Y
2,950 3,572 4,180 4,794
FY18 FY19 FY20 FY21
----- End of picture text -----

Highlights

• Personal Care contribution increased to 65.2% in FY21 (v/s 64% in FY20).

• Strong new customer wins across Personal Care categories; robust business development pipeline

17

EPL Limited Q4FY21 Earnings Presentation

Delivered strong progress across all our identified levers

• Accelerated growth in Personal Care

• Continued leadership in Oral Care

• Improved Performance in Europe

• Industry leadership in eco-friendly solutions

18

EPL Limited Q4FY21 Earnings Presentation

EPL has Established Global Leadership in Oral Care with the Segment Demonstrating Steady Long-Term Revenue Growth at a CAGR of 10.0%

Oral Care Revenue (INR million)

==> picture [596 x 97] intentionally omitted <==

----- Start of picture text -----

15,170
13,809
11,764 12,748 Growth 9.9%
9,203 Y-o-Y
5,823
FY11 FY13 FY15 FY17 FY20 FY21
----- End of picture text -----

==> picture [293 x 31] intentionally omitted <==

----- Start of picture text -----

Customers
----- End of picture text -----

==> picture [26 x 28] intentionally omitted <==

==> picture [27 x 25] intentionally omitted <==

==> picture [36 x 29] intentionally omitted <==

==> picture [24 x 28] intentionally omitted <==

==> picture [73 x 21] intentionally omitted <==

==> picture [30 x 28] intentionally omitted <==

==> picture [32 x 28] intentionally omitted <==

==> picture [50 x 21] intentionally omitted <==

==> picture [40 x 20] intentionally omitted <==

==> picture [49 x 20] intentionally omitted <==

==> picture [45 x 45] intentionally omitted <==

----- Start of picture text -----

1
----- End of picture text -----

Market Positioning

1. Market leader across key markets

2. Long term relationships with customers

3. Continued leadership through product and process innovation

4. Unique, agile, and customer-specific supply chain models

Business highlights

1. Wallet share gain with marquee global consumer companies. Global major added in Europe.

2. Market share gain from regional players in China.

3. Wallet share gain in the leading Oral brands in Americas

4. Oral care category grew in India with strong wallet share gain.

19

EPL Limited Q4FY21 Earnings Presentation

Delivered strong progress across all our identified levers

• Accelerated growth in Personal Care

• Continued leadership in Oral Care

• Improved Performance in Europe

• Industry leadership in eco-friendly solutions

20

EPL Limited Q4FY21 Earnings Presentation

Continued Growth Momentum in Europe across Oral and Personal Care Categories

Europe Revenue (INR million)

==> picture [640 x 159] intentionally omitted <==

----- Start of picture text -----

7,686
8,000
6,771
5,852
6,000 5,096
Growth Y-o-Y
4,000 13.5% Total
9.2% Oral Care
2,000
61% 62% 64% 65%
14.7% Personal Care
0
FY18 FY19 FY20 FY21
Personal Care Oral Care Others Personal Care as % of Tube Revenue
----- End of picture text -----

Efforts/Investments in last few quarters starting to show results

Impact

1. Strengthening of front-end organization

2. Accelerated growth across categories

3. Improved pipeline development process

4. With the recent key customer wins in Europe, EPL now serves all major Oral Care players in the region

5. Investments in capabilities and flexibilities

6. High customer engagement driven by best-in-class offerings and service levels

EPL continues to deliver robust growth driven by new customer wins and wallet share gain

21

EPL Limited Q4FY21 Earnings Presentation

Leading to Strong EBITDA Growth and Margin Improvement

Europe EBITDA[1] (INR million)

==> picture [573 x 155] intentionally omitted <==

----- Start of picture text -----

12.8% 14.8%
15.0%
10.0% 10.3% 1,137
10.0%
866
Growth 31.3%
511 603 Y-o-Y 5.0%
0.0%
FY18 FY19 FY20 FY21
EBITDA Margin
----- End of picture text -----

Key elements to profit growth

Impact

1. Revenue growth contributing to fixed cost leverage

2. Strong FY21 EBITDA[1] growth of 31.3% y-o-y

3. Shift towards premium products

4. Margin expansion by 200 bps y-o-y.

5. Lean initiatives and productivity improvement

6. Initiatives including operating leverage drives the improvement in EBIDTA margins.

7. Operations further optimized with the closure of Russia Manufacturing facility.

Sustained momentum will lead to continuous performance improvement

22

(1) Adjusted for ESOP Cost

EPL Limited Q4FY21 Earnings Presentation

Delivered strong progress across all our identified levers

• Accelerated growth in Personal Care

• Continued leadership in Oral Care

• Improved Performance in Europe

• Industry leadership in eco-friendly solutions

23

EPL Limited Q4FY21 Earnings Presentation

Sustainability: An Intrinsic Value at EPL

Platina laminated tubes fully recyclable in HDPE bottle stream

• Recognized and certified by APR / RecyClass / Cyclos

• Widest thickness range of tubes offering: 220u – 350u

• Designed to incorporate > 50% Green “Sustainably Sourced PE”

• Designed to incorporate > 30% PCR resins

==> picture [226 x 113] intentionally omitted <==

==> picture [119 x 119] intentionally omitted <==

==> picture [87 x 78] intentionally omitted <==

==> picture [145 x 40] intentionally omitted <==

24

EPL Limited Q4FY21 Earnings Presentation

Sustainability : “Leading the Pack”

Platina Pro - Next gen sustainable laminated tubes

• Fully recyclable tubes in HDPE bottle stream approved by APR and RecyClass

• Enhanced haptics

• Enhanced chemical resistance

• Enhanced flavor barrier

==> picture [80 x 158] intentionally omitted <==

==> picture [122 x 61] intentionally omitted <==

==> picture [105 x 105] intentionally omitted <==

Etain tubes with Post Consumer Recycled (PCR) resin content

• Eco-friendly tube from EPL with up to 30% PCR content in the tube wins the prestigious ETMA "Tube of the Year" Award 2020

• Successfully launched laminated tubes with up to 50% PCR content.

==> picture [150 x 215] intentionally omitted <==

==> picture [106 x 77] intentionally omitted <==

==> picture [110 x 110] intentionally omitted <==

Building a portfolio through industry-leading pipeline

• Platina vision

• Platina me

• Platina shine

• Platina pcrmax

• Platina biomax

25

EPL Limited Q4FY21 Earnings Presentation

Sustainability: A Promising Start

==> picture [196 x 327] intentionally omitted <==

First tube supplier in the world to get approval from APR for full tube along with barrier shoulder and cap

==> picture [185 x 358] intentionally omitted <==

Commercialization begins with 100 mm units

26

EPL Limited Q4FY21 Earnings Presentation

Corporate Social Responsibility

==> picture [47 x 42] intentionally omitted <==

Focus area:

EPL’s Strategy will focus on Sustainability and Sustainable Development with core values of Prosperity, Balance & Harmony, Vitality, Regeneration & Renewal, and Invigoration

==> picture [78 x 35] intentionally omitted <==

==> picture [43 x 31] intentionally omitted <==

Partnership:

EPL has Partnered with Samhita to build a comprehensive CSR strategy.

==> picture [41 x 49] intentionally omitted <==

Governance :

CSR Board Committee will review all the activities. In addition to this all the CSR activities will be governed by a 5 member CSR Governing Council consisting of the senior leaders of EPL.

==> picture [114 x 56] intentionally omitted <==

Our Vision: Greening Lives

Green communities:

Working on Waste management programs in communities to encourage and facilitate circular economy.

Support for Health care workers:

Donated INR 5 mm to India Protector Alliance via Collective Good Foundation to support India’s fight against COVID 19.

Provided PPE kits, hand sanitizers, masks and other medical equipment to several health care workers in India

27

EPL Limited Q4FY21 Earnings Presentation

Creative is a Subsidiary of EPL effective Feb 2021

• Transaction was consummated on 1[st] February 2021. The acquisition will help EPL further strengthen its position in the Personal Care segment.

 Enterprise Value: INR 2,539 mn

 Deal structure:

• Purchase of 72.5% stake through cash

• Purchase of balance 27.5% stake through issuance of 2.34 mm EPL shares to Creative founders pursuant to merger of Creative into EPL

• Creative founders will become part of EPL’s senior management team after the transaction and will play role in expansion of EPL’s global business.

• Merger process as per the scheme of merger approved by board of directors is ongoing.

28

EPL Limited Q4FY21 Earnings Presentation

Looking Ahead: FY22

==> picture [25 x 23] intentionally omitted <==

----- Start of picture text -----

1
----- End of picture text -----

Sustain double digit revenue growth

• Strong business development pipeline, FY22 entry 29% higher (April 2021 vs April 2020)

==> picture [25 x 23] intentionally omitted <==

----- Start of picture text -----

2
----- End of picture text -----

• Plan in place for Quarter-on-Quarter improvement in EBITDA margin through:

• Judicious price increases

• Cost productivity initiatives

• Mix improvement

==> picture [25 x 23] intentionally omitted <==

----- Start of picture text -----

3
----- End of picture text -----

Sustainability will be a key driver and EPL is leading the way for the industry.

4

We are committed to delivering market leading revenue growth and capital efficient, consistent earnings growth.

==> picture [25 x 24] intentionally omitted <==

----- Start of picture text -----

5
----- End of picture text -----

Severe Covid Wave 3 remains a concern.

29

EPL Limited Q4FY21 Earnings Presentation

==> picture [122 x 95] intentionally omitted <==

==> picture [104 x 83] intentionally omitted <==

==> picture [96 x 72] intentionally omitted <==

==> picture [35 x 95] intentionally omitted <==

Appendix

30

EPL Limited Q4FY21 Earnings Presentation

FY21: Adjusted EBITDA grew 13.4% Y-o-Y & Adjusted PAT grew 34.6% Y-o-Y

(INR million)

Adjustments	EBITDA	PAT1
Reported FY21 numbers	6,155	2,552
• China Tax refund	-	-25
• TSA2 related expenses	+160	+120
• One time acquisition related costs	+13	+13
• ESOP related cost	+144	+144
Adjusted FY21 numbers	6,472	2,804
Reported FY20 numbers	5,600	2,166
• China Tax refund	-	-112
• Tax benefit from one-time provision3	-	-51
• Tax amnesty	+11	+7
• TSA2 related expenses	+98	+73
Adjusted FY20 numbers	5,709	2,083
Like for Like Y-o-Y Growth (%)	13.4%	34.6%

(1) PAT excluding exceptional items; (2) Transition Services Agreement (3)Tax impact of provision of INR 203 mm taken for outstanding inter company deposits

31

EPL Limited Q4FY21 Earnings Presentation

Q4FY21: Adjusted EBITDA grew 5.3% Y-o-Y & Adjusted PAT grew 29.7% Y-o-Y

(INR million)

Adjustments	EBITDA	PAT1
Reported Q4FY21 numbers	1,416	568
• TSA2 related expenses	+40	+30
• One time acquisition related costs	+13	+13
• ESOP related cost	+58	+58
Adjusted Q4FY21 numbers	1,527	669
Reported Q4FY20 numbers	1,410	486
• TSA2 related expenses	+40	+30
Adjusted Q4FY20 numbers	1,450	516
Like for Like Y-o-Y Growth (%)	5.3%	29.7%

(1) PAT excluding exceptional items; (2) Transition Services Agreement

32

EPL Limited Q4FY21 Earnings Presentation

FY21 Regional Performance – 1/2

Revenue Split %

EBIT Split %

==> picture [511 x 167] intentionally omitted <==

----- Start of picture text -----

Europe,
Europe,
16%
24% AMESA,
AMESA,
28%
31%
Americas
, 18%
Americas
, 20%
EAP, EAP,
24% 37%
----- End of picture text -----

• The revenue grew by 12.0% Y-o-Y, majorly driven by EAP and EUROPE.

• Despite Covid-19, all regions contributed to the strong performance for the year.

• Strong business pipeline across regions to enable continued growth momentum

33

EPL Limited Q4FY21 Earnings Presentation

FY21 Regional Performance – 2/2

(INR million)

==> picture [494 x 287] intentionally omitted <==

----- Start of picture text -----

Revenue YoY Growth EBITDA [1] Margin
AMESA 9,934 6.1% 2,324 23.4%
EAP 7,820 25.5% 1,901 24.3%
Americas 6,521 5.4% 1,133 17.4%
Europe 7,686 13.5% 1,137 14.8%
----- End of picture text -----

(1) EBITDA is adjusted for ESOP cost for all the regions and also TSA related regions for AMESA

34

EPL Limited Q4FY21 Earnings Presentation

Q4FY21 Performance – AMESA and EAP

(INR million)

		AMESA
Particulars	Q4FY21	Q4FY20	% change
Revenue	2,766	2,158	28.2%
EBITDA	565	526	7.4%
EBITDA %	20.4%	24.4%
EBIT	310	281	10.3%
EBIT %	11.2%	13.0%
		EAP
Particulars	Q4FY21	Q4FY20	% change
Revenue	1,849	1,353	36.7%
EBITDA	329	259	27.0%
EBITDA %	17.8%	19.1%
EBIT	217	149	45.6%
EBIT %	11.7%	11.0%

EBITDA and EBIT is adjusted for ESOP cost for all the regions and also TSA related cost for AMESA

35

EPL Limited Q4FY21 Earnings Presentation

Q4FY21 Performance – Americas and Europe

(INR million)

			Americas
	Particulars	Q4FY21	Q4FY20	% change
	Revenue	1,749	1,715	2.0%
	EBITDA	309	390	-20.9%
	EBITDA %	17.6%	22.7%
	EBIT	207	297	-30.4%
	EBIT %	11.8%	17.3%
			Europe
	Particulars	Q4FY21	Q4FY20	% change
	Revenue	2,002	1,897	5.5%
	EBITDA	323	258	25.3%
	EBITDA %	16.1%	13.6%
	EBIT	196	135	45.3%
	EBIT %	9.8%	7.1%

EBITDA and EBIT is adjusted for ESOP cost for all the regions.

36

EPL Limited Q4FY21 Earnings Presentation

==> picture [121 x 93] intentionally omitted <==

==> picture [129 x 100] intentionally omitted <==

About EPL (Formerly known as Essel Propack Limited)

37

EPL Limited Q4FY21 Earnings Presentation

EPL: Company Overview

==> picture [636 x 260] intentionally omitted <==

----- Start of picture text -----

Largest Gl obal L ea der in Growing Strong
la m inated tubes Oral Care emergence in relationships
manufacturer Personal Care with marquee
FMCG customers
~8 bn Tubes #1 Globally 46% 20+ years
c o ntribution
Best in class Best in class Global Footprint Strong Innovation Platform
EBITDA Margins ROCE
- 66 patents granted
20+ factories
19.9% 21.3% 10+ countries - with sustainability focus
----- End of picture text -----

Note: Numbers on this page are as of 31 March, 2021. ROCE on trailing twelve month basis; adjusted for INR 160 mn of Transition Services Agreement (TSA) related expense and INR 144 mn of ESOP related expenses.

38

EPL Limited Q4FY21 Earnings Presentation

EPL Caters to Marquee Customers Across Trillion Dollar Categories

==> picture [501 x 123] intentionally omitted <==

==> picture [158 x 137] intentionally omitted <==

----- Start of picture text -----

Tube revenue split (FY21)
Personal Care,
46% 5%
11% Others
Pharma
54
30%
Beauty %
& Oral
Cosme
Care
tics
----- End of picture text -----

==> picture [29 x 26] intentionally omitted <==

==> picture [26 x 28] intentionally omitted <==

==> picture [53 x 29] intentionally omitted <==

==> picture [28 x 28] intentionally omitted <==

==> picture [66 x 15] intentionally omitted <==

==> picture [65 x 13] intentionally omitted <==

==> picture [52 x 20] intentionally omitted <==

==> picture [73 x 19] intentionally omitted <==

==> picture [36 x 34] intentionally omitted <==

==> picture [40 x 34] intentionally omitted <==

==> picture [40 x 32] intentionally omitted <==

==> picture [38 x 22] intentionally omitted <==

==> picture [43 x 23] intentionally omitted <==

==> picture [44 x 19] intentionally omitted <==

==> picture [52 x 15] intentionally omitted <==

==> picture [40 x 13] intentionally omitted <==

==> picture [33 x 28] intentionally omitted <==

==> picture [94 x 21] intentionally omitted <==

==> picture [31 x 28] intentionally omitted <==

==> picture [49 x 17] intentionally omitted <==

==> picture [59 x 23] intentionally omitted <==

==> picture [42 x 20] intentionally omitted <==

==> picture [98 x 7] intentionally omitted <==

==> picture [40 x 37] intentionally omitted <==

==> picture [54 x 31] intentionally omitted <==

==> picture [43 x 28] intentionally omitted <==

==> picture [59 x 23] intentionally omitted <==

==> picture [71 x 19] intentionally omitted <==

==> picture [66 x 17] intentionally omitted <==

==> picture [91 x 17] intentionally omitted <==

==> picture [65 x 24] intentionally omitted <==

==> picture [46 x 26] intentionally omitted <==

==> picture [42 x 21] intentionally omitted <==

==> picture [53 x 31] intentionally omitted <==

==> picture [44 x 34] intentionally omitted <==

==> picture [45 x 22] intentionally omitted <==

==> picture [52 x 18] intentionally omitted <==

==> picture [35 x 30] intentionally omitted <==

==> picture [9 x 7] intentionally omitted <==

----- Start of picture text -----

39
----- End of picture text -----

39

EPL Limited Q4FY21 Earnings Presentation

About EPL

EPL is the largest global specialty packaging company, manufacturing laminated plastic tubes catering to the FMCG and Pharma space. Employing over 3,366 people representing over 25 different nationalities, EPL functions in ten countries through 19 state of the art facilities, and is continuing to grow every year.

EPL is the world’s largest laminated tube manufacturer with units operating across countries such as USA, Mexico, Colombia, Poland, Germany, Egypt, Russia, China, Philippines and India. These facilities cater to diverse categories that include brands in Oral Care, Beauty & Cosmetics, Pharma & Health, Food, and Home, offering customized solutions through continuously pioneering firstin-class innovations in materials, technology and processes.

EPL ( Formerly known as Essel Propack Limited) CIN : L74950MH1982PLC028947

For further information contact:

Amit Jain amit.jain@eplglobal.com

40

Thank you

/esselofficial

==> picture [118 x 9] intentionally omitted <==

----- Start of picture text -----

/company/essel-propack-limited
----- End of picture text -----

==> picture [55 x 9] intentionally omitted <==

----- Start of picture text -----

/essel_propack
----- End of picture text -----

EPL LIMITED (Formerly known as Essel Propack Limited)

Top Floor, Times Tower, Kamala City Senapati Bapat Marg, Lower Parel Mumbai - 400 013, India